The M&A market for healthcare practices is on the rise again. After years of consolidation fatigue — driven in part by regulatory uncertainty — the past and current year have seen a noticeable revival.
Structural demand is meeting a growing supply of sellers willing to transact. Insolvent non-profit carriers, an ageing physician base without successors, and the decline of the solo practice as the dominant model of care are creating broad-based transaction pressure.
Hospital reform legislation, a constrained refinancing environment, and demographic shifts across the sector are forcing strategic decisions that were previously deferred. At the same time, financial investors are returning. On the valuation side, the market remains bifurcated: while overall valuation levels remain well below pre-COVID benchmarks, scalable MVZ structures with an attractive specialty profile are achieving EBITDA multiples of 6–8x.
In our Sector Insight, we speak with Prof. Dr. Thomas Schlegel, founding partner of the healthcare law firm Prof. Schlegel, Hohmann, Diarra und Partner, about the outlook for M&A in the healthcare professions — covering returning buyer groups, specialties in strategic focus, and the decisive success factors in regulated-environment transactions. Prof. Dr. Schlegel shares insights into current market movements, structural trends, and practical experience from advising on transactions in the regulated healthcare sector. Read more on page 3 of the SektorReport Healthcare Q2 2026.
In our Deal Report, we examine the acquisition of the surgical MVZ Wissen by Marien Ambulant gGmbH — a transaction that exemplifies a growing trend: faith-based healthcare groups are leveraging insolvency situations as strategic acquisition windows to systematically expand their ambulatory market position. Read more on page 5 of the SektorReport Healthcare Q2 2026.
Our SektorReports are available in German language. If you have further questions regarding this topic, feel free to get in touch.